These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2294819)
21. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine. Ward J Pediatrics; 1990 Apr; 85(4 Pt 2):667. PubMed ID: 2179858 [No Abstract] [Full Text] [Related]
22. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904 [TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group. Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474 [TBL] [Abstract][Full Text] [Related]
24. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. Weinberg GA; Granoff DM J Pediatr; 1988 Oct; 113(4):621-31. PubMed ID: 3050001 [No Abstract] [Full Text] [Related]
25. Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine. Gigliotti F; Feldman S; Wang WC; Day SW; Brunson G J Pediatr; 1989 Jun; 114(6):1006-10. PubMed ID: 2786061 [No Abstract] [Full Text] [Related]
26. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom. Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine. Weinberg GA; Granoff DM Pediatrics; 1990 Apr; 85(4 Pt 2):654-61. PubMed ID: 2179856 [No Abstract] [Full Text] [Related]
28. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep; 1991 Jan; 40(RR-1):1-7. PubMed ID: 1899280 [TBL] [Abstract][Full Text] [Related]
29. Pediatrics academy issues recommendations on use of Haemophilus influenzae type b conjugate vaccine. Clin Pharm; 1988 Sep; 7(9):634. PubMed ID: 3266482 [No Abstract] [Full Text] [Related]
30. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children. Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012 [TBL] [Abstract][Full Text] [Related]
31. Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Claesson BA; Trollfors B; Anderson PW; Johansson J; Taranger J; Schneerson R; Robbins JB Pediatr Infect Dis J; 1996 Feb; 15(2):170-2. PubMed ID: 8822293 [No Abstract] [Full Text] [Related]
32. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis. Wenger JD; Ward JI; Broome CV Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698 [No Abstract] [Full Text] [Related]
34. Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers. Anderson PW; Stein EC; Insel RA Contrib Microbiol Immunol; 1989; 10():115-24. PubMed ID: 2684504 [No Abstract] [Full Text] [Related]
35. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine. Mäkelä PH; Käyhty H; Peltola H; Eskola J Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S73-5. PubMed ID: 2648298 [No Abstract] [Full Text] [Related]
36. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B; Wald E; Guerra N; Byers C Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519 [TBL] [Abstract][Full Text] [Related]